- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Banner|Aetna: Collaboration as a Business Imperative, Part 2
Leaders from Banner|Aetna discuss the joint venture that has grown to 375,000 members since it launched in 2017 to offer health plans to employers in Arizona.
In this episode of Matters in Managed Care, leaders from Banner|Aetna discuss the joint venture that has grown to 375,000 members since it launched in 2017 to offer health plans to employers in Arizona. The venture has since expanded into the individual market.
Robert Groves, MD, Banner|Aetna’s executive vice president and chief medical officer, served as moderator for a discussion that outlines how under the model, the delivery system and payer became co-owners of the plan, with equal investment and risk in the outcome.
Along with Dr Groves, the webinar features the following panelists:
- Thomas J. Grote, CEO, Banner|Aetna
- Chuck Lehn, president, Banner Health Network
- Marjorie Bessel, MD, chief clinical officer, Banner Health
In part 2, the panelists discuss the shift from high-risk management to patient engagement.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
